FMOC-DAP(FMOC)-OH
|
|
FMOC-DAP(FMOC)-OH Eigenschaften
- Siedepunkt:
- 784.4±60.0 °C(Predicted)
- Dichte
- 1.491±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- pka
- 3.47±0.10(Predicted)
- CAS Datenbank
- 140430-54-2
Sicherheit
WGK Germany | 3 | ||
---|---|---|---|
F | 10 | ||
HazardClass | IRRITANT |
FMOC-DAP(FMOC)-OH Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Yellow crystalline powderVerwenden
Fmoc-dap(dnp)-oh is an intermediate used in the preparation of DOTA containing peptides as MMP-2-activated agents for cancer imaging.FMOC-DAP(FMOC)-OH Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
FMOC-DAP(FMOC)-OH Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 88)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Shanghai Daken Advanced Materials Co.,Ltd | +86-371-66670886 |
info@dakenam.com | China | 19881 | 58 |
GenicBio Limited | +86-21-37621270 |
service@genicbio.com | CHINA | 991 | 58 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
sales@coreychem.com | China | 29869 | 58 |
Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 |
sales@chemdad.com | China | 39894 | 58 |
Alchem Pharmtech,Inc. | 8485655694 |
sales@alchempharmtech.com | United States | 63687 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49732 | 58 |
GL Biochem(Binhai) Ltd. | +86-021-61263370 +8615301650015 |
wuqiuyan@glschina.com | China | 2975 | 58 |
BOC Sciences | 16314854226; +16314854226 |
inquiry@bocsci.com | United States | 19741 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 |
sales@huarongpharm.com | CHINA | 3148 | 58 |
Nextpeptide Inc | +86-0571-81612335 +8613336028439 |
sales@nextpeptide.com | China | 19908 | 58 |
140430-54-2()Verwandte Suche:
- RARECHEM EM WB 0112
- N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-BETA-(2,4-DINITRO-PHENYL)-L-2,3-DIAMINOPROPIONIC ACID
- L-ALANINE, N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-3-[[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO]-
- FMOC-3-(FMOC-AMINO)-L-ALANINE
- FMOC-N-BETA-2,4-DINITROPHENYL-L-2,3-DIAMINOPROPIONIC ACID
- FMOC-(N-BETA-(2,4-DINITROPHENYL))-L-ALPHA,BETA-DIAMINOPROPIONIC ACID
- FMOC-ALPHA,BETA-DIAMINOPROPIONIC ACID(DNP)-OH
- FMOC-ALPHA,BETA-DIAMINOPROPIONIC ACID(FMOC)-OH
- FMOC-DAP(DNP)-OH
- FMOC-DAP(FMOC)-OH
- FMOC-L-DAPA(FMOC)-OH
- FMOC-L-DAP(DNP)-OH
- FMOC-L-DAP(FMOC)-OH
- FMOC-L-DPA(FMOC)-OH
- FMOC-DPR(FMOC)-OH
- DI-FMOC-L-ALPHA,BETA-DIAMINOPROPIONIC ACID
- N-α-Fmoc-N-β-2,4-dinitrophenyl-L-2,3-diaminopropionic acid
- N-ALPHA-(9-FLUOROENYLMETHYLOXYCARBONYL)-N-BETA-(2,4-DINITROPHENYL)-L-2,3-DIAMINOPROPIONIC ACID
- N-.ALPHA.-FMOC-N-.BETA.-2,4-DINITROPHENYL-L-2,3-DIAMINOPROPIONIC ACID
- (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2,4-dinitrophenylamino)propanoic acid
- N-α-Fmoc-N-β-2,4-dinitrophenyl-L-2,3-diaminoprop
- N-beta-2,4-Dinitrophenyl Fmoc-l-diaminopropionicacid
- FMoc-Dap(Dnp)-OH N-α-FMoc-N-β-2,4-dinitrophenyl-L-2,3-diaMinopropionic acid
- FMoc-Dpa-OH
- N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-BETA-(2,4-DINITROPHENYL)-L-2,3-DIAMINOPROPIONIC ACID
- N-ALPHA,BETA-BIS-FMOC-L-2,3-DIAMINOPROPIONIC ACID
- N-ALPHA,BETA-DI-FMOC-L-ALPHA,BETA-DIAMINOPROPIONIC ACID
- N-ALPHA, BETA-DI-(9-FLUORENYLMETHOXYCARBONYL)-L-DIAMINOPROPIONIC ACID
- N-ALPHA,N-BETA-DI-FMOC-(S)-2,3-DIAMINOPROPIONIC ACID
- N-ALPHA-N-BETA-BIS-(9-FLUORENYLMETHYLOXYCARBONYL)-L-2,3-DIAMINOPROPIONIC ACID
- N-ALPHA-N-BETA-BIS-FMOC-L-DIAMINOPROPIONIC ACID
- NALPHA,NBETA-DI-FMOC-L-2,3-DIAMINOPROPIONIC ACID
- N-ALPHA-FMOC-N-BETA-(2,4-DINITROPHENYL)-L-ALPHA,BETA-DIAMINOPROPIONIC ACID
- (S)-3-(2,4-DinitrophenylaMino)-2-(FMoc-aMino)propionic acid, 95%
- Nα-Fmoc-Nβ-2,4-dinitrophenyl-L-2,3-diaminopropionic acidSolvate with Toluene≥ 99% (HPLC)
- (9H-Fluoren-9-yl)MethOxy]Carbonyl Dap(Dnp)-OH
- Fmoc-Dap(Dnp)-OH (Fmoc-Dpa-OH)
- (2S)-3-[(2,4-dinitrophenyl)amino]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid
- L-Alanine, 3-[(2,4-dinitrophenyl)amino]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
- Nα-Fmoc-Nβ-2,4-dinitrophenyl-L-2,3-diaminopropionic acid
- Fmoc-(N-beta-(2,4-dinitrophenyl))-L-alpha,beta-diaminopropionicaci
- 140430-54-2
- C33H28N2O6
- C24H20N4O8
- DAP (2,3-Diaminopropionic Acid)
- Peptide Synthesis
- Specialty Synthesis
- Unnatural Amino Acid Derivatives
- amino acids